Investors in Padlock Therapeutics have accused Bristol Myers Squibb of reneging on payments of up to $450 million negotiated ...

Gilead plans to begin Phase 3 testing soon for a drug it believes could prevent HIV infection with a single shot every year ...

As health insurers use AI to deny more claims, startups are turning to AI to make it easier to appeal denials, which often go ...

I just returned from San Diego and the annual meeting of the American Society of Hematology, where Arcellx won the battle of ...

Stoke Therapeutics is nearing FDA sign-off on a groundbreaking Phase 3 clinical trial for its experimental drug for Dravet ...

Akshara Ramasamy will soon begin medical school in Texas — but the state’s new requirement to ask hospital patients about ...

As we approach the end of 2024, First Opinion is publishing a series of essays on the state of AI in medicine and biopharma. ...

"Our policies are saving lives,” Biden officials say about the drop in drug overdose deaths. Experts say that may not be the ...

Is it just me, or was it dark at, like, 2:30 pm in Boston yesterday? “Winter is coming,” as George R. R. Martin’s House Stark ...

Pfizer said Thursday its drug Ibrance showed efficacy in a group of breast cancer patients who do not currently have access ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Investigators trying to determine how a child in California might have contracted bird flu are continuing to learn more ...